miRNAs released from exosomes appear to be associated with multiple neurodegenerative conditions linking to Alzheimer's disease (AD) which is marked by hyperphosphorylated tau proteins and accumulation of Aβ plaques. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.